Literature DB >> 21893534

Vaccines and global health.

Brian Greenwood1, David Salisbury, Adrian V S Hill.   

Abstract

Vaccines have made a major contribution to global health in recent decades but they could do much more. In November 2011, a Royal Society discussion meeting, 'New vaccines for global health', was held in London to discuss the past contribution of vaccines to global health and to consider what more could be expected in the future. Papers presented at the meeting reviewed recent successes in the deployment of vaccines against major infections of childhood and the challenges faced in developing vaccines against some of the world's remaining major infectious diseases such as human immunodeficiency virus (HIV), malaria and tuberculosis. The important contribution that development of more effective veterinary vaccines could make to global health was also addressed. Some of the social and financial challenges to the development and deployment of new vaccines were reviewed. The latter issues were also discussed at a subsequent satellite meeting, 'Accelerating vaccine development', held at the Kavli Royal Society International Centre. Delegates at this meeting considered challenges to the more rapid development and deployment of both human and veterinary vaccines and how these might be addressed. Papers based on presentations at the discussion meeting and a summary of the main conclusions of the satellite meeting are included in this issue of Philosophical Transactions of the Royal Society B.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21893534      PMCID: PMC3146775          DOI: 10.1098/rstb.2011.0076

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  43 in total

Review 1.  Economic costs of the foot and mouth disease outbreak in the United Kingdom in 2001.

Authors:  D Thompson; P Muriel; D Russell; P Osborne; A Bromley; M Rowland; S Creigh-Tyte; C Brown
Journal:  Rev Sci Tech       Date:  2002-12       Impact factor: 1.181

2.  A universal vaccine for serogroup B meningococcus.

Authors:  Marzia M Giuliani; Jeannette Adu-Bobie; Maurizio Comanducci; Beatrice Aricò; Silvana Savino; Laura Santini; Brunella Brunelli; Stefania Bambini; Alessia Biolchi; Barbara Capecchi; Elena Cartocci; Laura Ciucchi; Federica Di Marcello; Francesca Ferlicca; Barbara Galli; Enrico Luzzi; Vega Masignani; Davide Serruto; Daniele Veggi; Mario Contorni; Maurizio Morandi; Alessandro Bartalesi; Vanda Cinotti; Donatella Mannucci; Francesca Titta; Elisa Ovidi; Jo Anne Welsch; Dan Granoff; Rino Rappuoli; Mariagrazia Pizza
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-06       Impact factor: 11.205

3.  Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness.

Authors:  David M Morens; Jeffery K Taubenberger; Anthony S Fauci
Journal:  J Infect Dis       Date:  2008-10-01       Impact factor: 5.226

Review 4.  Foot and mouth disease virus vaccines.

Authors:  Luis L Rodriguez; Marvin J Grubman
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

Review 5.  Vaccines against nicotine.

Authors:  Erich H Cerny; Thomas Cerny
Journal:  Hum Vaccin       Date:  2009-04-02

6.  Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.

Authors:  Supachai Rerks-Ngarm; Punnee Pitisuttithum; Sorachai Nitayaphan; Jaranit Kaewkungwal; Joseph Chiu; Robert Paris; Nakorn Premsri; Chawetsan Namwat; Mark de Souza; Elizabeth Adams; Michael Benenson; Sanjay Gurunathan; Jim Tartaglia; John G McNeil; Donald P Francis; Donald Stablein; Deborah L Birx; Supamit Chunsuttiwat; Chirasak Khamboonruang; Prasert Thongcharoen; Merlin L Robb; Nelson L Michael; Prayura Kunasol; Jerome H Kim
Journal:  N Engl J Med       Date:  2009-10-20       Impact factor: 91.245

Review 7.  Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates.

Authors:  Katherine L O'Brien; Lara J Wolfson; James P Watt; Emily Henkle; Maria Deloria-Knoll; Natalie McCall; Ellen Lee; Kim Mulholland; Orin S Levine; Thomas Cherian
Journal:  Lancet       Date:  2009-09-12       Impact factor: 79.321

8.  Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study.

Authors:  Alain C Tissot; Patrik Maurer; Juerg Nussberger; Robert Sabat; Thomas Pfister; Stanislav Ignatenko; Hans-Dieter Volk; Hans Stocker; Philipp Müller; Gary T Jennings; Frank Wagner; Martin F Bachmann
Journal:  Lancet       Date:  2008-03-08       Impact factor: 79.321

9.  Accelerating vaccine development and deployment: report of a Royal Society satellite meeting.

Authors:  Migena Bregu; Simon J Draper; Adrian V S Hill; Brian M Greenwood
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-10-12       Impact factor: 6.237

10.  Bluetongue epidemiology in the European Union.

Authors:  Claude Saegerman; Dirk Berkvens; Philip S Mellor
Journal:  Emerg Infect Dis       Date:  2008-04       Impact factor: 6.883

View more
  7 in total

1.  Access to new technologies in multipatented vaccines: challenges for Brazil.

Authors:  Cristina Possas; Adelaide Maria de Souza Antunes; Flavia Maria Lins Mendes; Suzanne de Oliveira Rodrigues Schumacher; Reinaldo Menezes Martins; Akira Homma
Journal:  Nat Biotechnol       Date:  2015-06       Impact factor: 54.908

2.  On the Design of Hyperstable Feedback Controllers for a Class of Parameterized Nonlinearities. Two Application Examples for Controlling Epidemic Models.

Authors:  Manuel De la Sen
Journal:  Int J Environ Res Public Health       Date:  2019-07-27       Impact factor: 3.390

Review 3.  Virus-Based Nanoparticles as Versatile Nanomachines.

Authors:  Kristopher J Koudelka; Andrzej S Pitek; Marianne Manchester; Nicole F Steinmetz
Journal:  Annu Rev Virol       Date:  2015-09-25       Impact factor: 10.431

4.  Exploring Leishmania secretory proteins to design B and T cell multi-epitope subunit vaccine using immunoinformatics approach.

Authors:  Nazia Khatoon; Rajan Kumar Pandey; Vijay Kumar Prajapati
Journal:  Sci Rep       Date:  2017-08-15       Impact factor: 4.379

5.  Novel LysM motifs for antigen display on lactobacilli for mucosal immunization.

Authors:  Julio Villena; Maria Guadalupe Vizoso-Pinto; Fernanda Raya-Tonetti; Melisa Müller; Jacinto Sacur; Haruki Kitazawa
Journal:  Sci Rep       Date:  2021-11-04       Impact factor: 4.379

6.  Dynamics of the major histocompatibility complex class I processing and presentation pathway in the course of malaria parasite development in human hepatocytes: implications for vaccine development.

Authors:  Jinxia Ma; Stefanie Trop; Samantha Baer; Elian Rakhmanaliev; Zita Arany; Peter Dumoulin; Hao Zhang; Julia Romano; Isabelle Coppens; Victor Levitsky; Jelena Levitskaya
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240

7.  Carbohydrate-based ice recrystallization inhibitors increase infectivity and thermostability of viral vectors.

Authors:  Shahrokh M Ghobadloo; Anna K Balcerzak; Ana Gargaun; Darija Muharemagic; Gleb G Mironov; Chantelle J Capicciotti; Jennie G Briard; Robert N Ben; Maxim V Berezovski
Journal:  Sci Rep       Date:  2014-07-31       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.